A new, billion-dollar pharmaceutical to treat peanut allergies is up for approval. It’s simply peanut flour. James Hamblin. 12:12 PM ET. 4 more free articles this month Already a subscriber? Sign in. Thank you for reading The Atlantic. Thank you for reading The …
See Original Article

The FBI and the New York State Department of Labor confirmed this week they are investigating allegations that a widely-used payroll company diverted nearly $35 million in employee pay to its own bank account before abruptly closing up shop, leaving …
See Original Article

U.S. stocks traded mostly higher early Friday, extending an up trend that has put the Dow and S&P 500 within striking distance of fresh all-time highs as Sino-American trade tensions ease and central banks support risk taking with economic stimulus …
See Original Article

Shares of cloud-based cybersecurity Cloudflare (NET) rose in their trading debut on Friday with the stock gaining nearly 25% to $18.73 from its initial public offering price of $15 despite concerns about the company’s more recent disclosure of potential U.S. …
See Original Article

PHILADELPHIA (CBS) — It’s been two weeks since Dorian decimated the Bahamas as a Category 5 hurricane, killing at least 42 people, with 1,300 more missing and feared dead, as another tropical storm is heading their way. Philadelphia’s Caribbean …
See Original Article